New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Niagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

A study links living near golf courses to higher Parkinson's risk, with strongest association found in those one to three ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...

Parkinson's disease often begins asymmetrically, affecting either the right or left side of the body first. Researchers from ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

Parkinson’s disease, the second most common neurodegenerative disorder globally, is often associated with vocal impairments, ...